Transparency Disclosure — We may receive a referral fee for products purchased through the links on our site…Read More.

Philips Discontinues Sleep Apnea and Respiratory Machines Over Safety Concerns

Philips Respironics has announced1 that they are updating their inventory and halting sales on certain sleep apnea and respiratory devices, including hospital ventilation products, certain home ventilation products, portable and stationary oxygen concentrators, and sleep diagnostic products. 

Among those products is the brand’s portable CPAP device, the DreamStation Go. The areas affected by the change include the United States and U.S. territories. Philips announced the following list of products impacted by change:

  • Alice 6 – Sleep Diagnostic Machine
  • Alice NightOne – Sleep Diagnostic Machine
  • Alice PDx – Sleep Diagnostic Machine
  • CoughAssist – Airway Clearance Device
  • DreamStation Go – Portable PAP Therapy System
  • E30 – Ventilation Solution
  • EverFlo – Home Oxygen System
  • I-neb AAD Nebulizer – Respiratory Drug Delivery
  • Millennium M10 – Home Oxygen System
  • NightBalance – Positional Sleep Therapy Device
  • OmniLab Advanced + – Titration System
  • Other nebulizers – Respiratory Drug Delivery
  • Other RDD products – Respiratory Drug Delivery
  • SimplyGo – Portable Oxygen Concentrator
  • SimplyGo Mini – Portable Oxygen Concentrator
  • Trilogy 100/200/202 – Portable Ventilator
  • Trilogy EVO and EV300 – Home Ventilator
  • V30 – Ventilator
  • V60 / V60 Plus – Ventilator

The move to stop manufacturing and selling these products comes after the FDA reported 561 deaths2 that they say were allegedly linked to PE-PUR foam in the machines breaking down. According to the FDA, PE-PUR is a polyester-based polyurethane foam that was used in these medical devices to minimize sound and vibrations.

Philips originally began recalling products in June 2021, which included certain ventilators, BiPAP machines, and CPAP machines.2 

On their website, though, Philips stated that the new changes to their sales portfolio won’t impact the remediation of the CPAP, BiPAP, and ventilator devices impacted by that June 2021 recall.1

CBS News3 reports that Philips agreed to discontinue sales of these machines in the U.S. following a settlement with the FDA and Justice Department, adding that it may cost Philips upwards of $400 million.

If you have any questions about the recently discontinued products or those impacted by the earlier recall, you can contact Philips Customer Service at 800-345-6443.

For those looking into alternative CPAP devices, we encourage you to visit our list of the best CPAP machines and consult your healthcare provider.

Jill Zwarensteyn

Jill Zwarensteyn


About Author

Jill Zwarensteyn is the Editor for Sleep Advisor and a Certified Sleep Science Coach. She is enthusiastic about providing helpful and engaging information on all things sleep and wellness.

Combination Sleeper


  1. “Sleep & Respiratory Product Portfolio Changes”. Philips Respironics. Last modified February 6, 2024.
  2. “UPDATE: Certain Philips Respironics Ventilators, BiPAP Machines, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication”. U.S. Food and Drug Administration. Last modified January 31, 2024.
  3. Gibson, Kate. “FDA says 561 deaths tied to recalled Philips sleep apnea machines”. CBS News. 2024.